Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Alison Hirukawa(Biogen (United States)), William J. Muller(McGill University Health Centre)
Cited by 84
Related Papers
Oncogenes and Tumor Suppressor Genes
|Cold Spring Harbor Perspectives in Biology|2010|504
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
|The EMBO Journal|2008|159
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
|Journal of Biological Chemistry|2009|78
Targeting fatty acid oxidation enhances response to HER2-targeted therapy
|Nature Communications|2024|50
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
|Journal of Clinical Investigation|2023|36